513 Trial in progress: phase 1 first-in-human study of XL092 administered alone or in combination with immune checkpoint inhibitors in patients with inoperable locally advanced or metastatic solid tumors
oleh: Vivek Subbiah, Neeraj Agarwal, Sumanta Pal, Amita Patnaik, Manish Sharma, Edward Cha, Geoffrey Shapiro, Kristopher Wentzel, Elizabeth McIlvaine, Jana Waldes, Keyvan Tadjalli-Mehr
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.